CNS Summit Podcast

Hear how Dr. Amy Abernethy, Principle Deputy Commissioner and current Acting CIO of the FDA sees the role of technology, including AI and RWE in the drug development landscape. Fi...

Hear how Ali Parsa, CEO of Babylon Health sees the future of enabling accessible and affordable health service to every person on earth using quantum computing, 5G networks, IoT, p...

Hear how Jessica Mega, Chief Medical and Scientific Officer at Verily, sees the intersection of life science, healthcare and technology through research programs, such as Project B...

Hear how MIT Professor Dina Katabi sees the future of neurodegenerative diseases like Parkinson's and Huntington's, mood disorders and GI and Immune system diseases with applicatio...

Hear how George Goldsmith and Ekaterina Malievskaia from COMPASS Pathways are working to bring innovation psychedelic drug applications for depression. Learn what what this means f...

This is a special episode of a webinar that was recorded on Friday, May 8, 2020. In this recording, we hear from Dr. Amy Abernethy, Principal Deputy Commissioner and Acting CIO of ...

Eric is currently Chief Science Officer at Datavant and Visiting Scientist at the Department of Biomedical Informatics at Harvard Medical School. Most recently, Eric was Senior Vic...

Deborah Dunsire is the CEO and President of Lundbeck. Prior to that, she was the CEO and President of FORUM Pharmaceuticals and the CEO and President at Millennium Pharmaceuticals....

Vivek Ramaswamy is the founder and CEO of Roivant Sciences, the parent of a growing family of companies focused on diverse areas including women’s health, rare diseases, neurology,...

Hi everyone this is Amir Kalali. I am a physician researcher focused on the intersection of life sciences and technology. Welcome to the CNS Summit podcasts, a new series of podcas...